// App-Quantinova.ai

: Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Researchers

Presenter

  • Deborah Y. Park

Principal Investigators

  • Shyam K. Poudel

  • Xuefei Jia

  • Mailey Lynn Wilks

  • Vicki Pinkava

  • Meghan O'Brien

  • Barbara Tripp

  • Jung-Min Song

  • Keith R. McCrae

  • Dana E. Angelini

  • Alok A. Khorana

Medical Centers

  • Cleveland Clinic Lerner College of Medicine, Cleveland Heights, OH

  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

  • Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Gastroenterology (GU)

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Gastric Cancer

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Thrombocytopenia

  • Gastroesophageal reflux disease

  • Ulcerative colitis

  • Solid malignancies

Biomarkers

  • Catalase

Drug/Treatment

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A

Study Design

  • Multinational

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved